Abraham Pomerantz

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in YayYo, Inc. of Class Action Lawsuit and Upcoming Deadline - YAYO

Saturday, October 17, 2020 - 9:59pm

To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.

Key Points: 
  • To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • YayYo, Inc., through its subsidiaries, engages in developing vehicle rental platform in the United States.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ultra Petroleum Corporation of Class Action Lawsuit and Upcoming Deadline - UPLCQ

Saturday, October 17, 2020 - 9:54pm

NEW YORK, Oct. 17, 2020 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against certain officers of Ultra Petroleum Corporation ("Ultra Petroleum" or the "Company") (OTCMKTS: UPLCQ).

Key Points: 
  • NEW YORK, Oct. 17, 2020 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against certain officers of Ultra Petroleum Corporation ("Ultra Petroleum" or the "Company") (OTCMKTS: UPLCQ).
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Non-party Ultra is a petrochemical company focused on developing its natural gas reserves located in southwest Wyoming.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Precigen, Inc (f/k/a Intrexon Corporation) - PGEN

Saturday, October 17, 2020 - 9:22pm

NEW YORK, Oct. 17, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Precigen, Inc (f/k/a Intrexon Corporation) (Precigen or the Company) (NASDAQ:PGEN).

Key Points: 
  • NEW YORK, Oct. 17, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Precigen, Inc (f/k/a Intrexon Corporation) (Precigen or the Company) (NASDAQ:PGEN).
  • Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.
  • The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Reata Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – RETA

Saturday, October 17, 2020 - 9:06pm

NEW YORK, Oct. 17, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Reata Pharmaceuticals, Inc. (Reata or the Company) (NASDAQ: RETA) and certain of its officers.

Key Points: 
  • NEW YORK, Oct. 17, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Reata Pharmaceuticals, Inc. (Reata or the Company) (NASDAQ: RETA) and certain of its officers.
  • If you are a shareholder who purchased Reata securities during the class period, you have until December 14, 2020, to ask the Court to appoint you as Lead Plaintiff for the class.
  • To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pintec Technology Holdings Limited - PT

Saturday, October 17, 2020 - 9:02pm

NEW YORK, Oct. 17, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Pintec Technology Holdings Limited (Pintec or the Company) (NASDAQ:PT).

Key Points: 
  • NEW YORK, Oct. 17, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Pintec Technology Holdings Limited (Pintec or the Company) (NASDAQ:PT).
  • Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext.
  • In October 2018, Pintec completed its initial public offering (IPO), selling more than 3.7 million American Depositary Shares (ADSs) priced at $11.88 per share.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech, Inc. - FBIO

Thursday, October 15, 2020 - 2:08am

NEW YORK, Oct. 14, 2020 /PRNewswire/ --Pomerantz LLP is investigating claims on behalf of investors ofFortress Biotech, Inc.("Fortress Biotech" or the "Company")(NASDAQ:FBIO).

Key Points: 
  • NEW YORK, Oct. 14, 2020 /PRNewswire/ --Pomerantz LLP is investigating claims on behalf of investors ofFortress Biotech, Inc.("Fortress Biotech" or the "Company")(NASDAQ:FBIO).
  • Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext.
  • The investigation concerns whether Fortress Biotech and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teva Pharmaceuticals Industries Limited of Class Action Lawsuit and Upcoming Deadline – TEVA

Tuesday, October 13, 2020 - 1:00pm

NEW YORK, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Teva Pharmaceuticals Industries Limited (Teva or the Company) (NYSE: TEVA) and certain of its officers.

Key Points: 
  • NEW YORK, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Teva Pharmaceuticals Industries Limited (Teva or the Company) (NYSE: TEVA) and certain of its officers.
  • If you are a shareholder who purchased Teva securities during the class period, you have until November 23, 2020, to ask the Court to appoint you as Lead Plaintiff for the class.
  • To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Homology Medicines, Inc. - FIXX

Tuesday, October 13, 2020 - 4:46am

NEW YORK, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Homology Medicines, Inc. (Homology or the Company) (NASDAQ: FIXX).

Key Points: 
  • NEW YORK, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Homology Medicines, Inc. (Homology or the Company) (NASDAQ: FIXX).
  • Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.
  • The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACM Research, Inc. - ACMR

Tuesday, October 13, 2020 - 4:32am

NEW YORK, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ACM Research, Inc. (ACM or the Company) (NASDAQ:ACMR).

Key Points: 
  • NEW YORK, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ACM Research, Inc. (ACM or the Company) (NASDAQ:ACMR).
  • Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext.
  • On October 8, 2020, analyst J Capital Research (J Capital) published a report concerning ACM, in which J Capital concluded that ACM is a fraud, over-reporting both revenue and profit.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in GoHealth, Inc. of Class Action Lawsuit and Upcoming Deadline – GOCO

Tuesday, October 13, 2020 - 4:32am

To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.

Key Points: 
  • To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • GoHealth provides an end-to-end health insurance marketplace that purportedly specializes in matching consumers with Medicare Advantage plans.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.